Q4 results: Sun Pharma, Hindalco, ONGC, Cipla, Bhel
Sun Pharmaceutical Industries, India's third-largest drugmaker by revenue, reported a 57 percent jump in fourth-quarter net profit, slightly above expectations, helped by higher sales in the United States, its largest market.
04:27- 03:06
- 01:45
- 01:56
- 02:21
- 03:16
- 01:20
- 03:44
- 02:41
- 00:41
- 01:00
- 01:09
- 01:20
- 00:50
- 01:50
- 06:30
- 07:21
- 02:12
- 02:16
- 02:14
- 01:30
- 02:54
- 01:35
- 00:29
- 03:26
- 02:12
- 01:56
- 02:32
- 04:13
- 05:48
- 08:21
- 03:58
- 01:36
- 02:02
- 04:49
- 01:20
- 01:56
- 04:47
- 01:17
- 01:17
Related Videos
